Panacur Equine Granules 22.2 % w/w

מדינה: אירלנד

שפה: אנגלית

מקור: HPRA (Health Products Regulatory Authority)

מרכיב פעיל:

Fenbendazole

זמין מ:

Intervet Ireland Limited

קוד ATC:

QP52AC13

INN (שם בינלאומי):

Fenbendazole

כמות:

22.2 percent weight/weight

טופס פרצבטיות:

Granules

סוג מרשם:

POM: Prescription Only Medicine as defined in relevant national legislation

קבוצה תרפויטית:

Horses

איזור תרפויטי:

fenbendazole

סממני תרפויטית:

Endoparasiticide

מצב אישור:

Authorised

תאריך אישור:

1999-10-01

מאפייני מוצר

Health Products Regulatory Authority
24 November 2017
CRN000VD4
Page 1 of 5
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Panacur Equine Granules 22.2 % w/w
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
​
Each g contains:
​
​
ACTIVE SUBSTANCE:
​
​
Fenbendazole
​222 mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Granules.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses and other equines.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of immature and mature stages of nematodes of the
gastro-intestinal and respiratory tracts of horses and other equines.
Sensitive endoparasites include adult and immature (larval) stages of:
Large strongyles
Small strongyles
Ascarids
_Oxyuris equi_
_Dictyocaulus arnfeldi_
Panacur is effective for the treatment of migrating strongyle
infections and inhibited
cyathostome larvae in the large intestine mucosa.
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance.
Health Products Regulatory Authority
24 November 2017
CRN000VD4
Page 2 of 5
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately result in
ineffective therapy:
- Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
- Underdosing, which may be due to underestimation of body weight,
misadministration of the product, or lack of calibration of the dosing
device.
Suspected clinical cases of resistance to anthelmintics should be
further investigated
using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where
the results of
the test(s) strongly suggest resistance to a particular anthelmintic,
an anthelmintic
belonging to another pharmacological class and having a different mode
of action
should be used.
Resistance to benzimidazoles has been reported in gastro-intestinal
nematodes in
horses. Therefore, the use of this product should be based on local
epidemiological